Search research articles
Contact Us
Filters
Showing results (361-370 of 386) with videos related to
Page
of 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2004
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group
Howard I Scher, Mario Eisenberger, Anthony V D'Amico, et al.
Cancer Research Communications
|
July 30, 2024
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial
Channing J Paller, Marianna L Zahurak, Adel Mandl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2017
Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial
Channing J Paller, Xian C Zhou, Elisabeth I Heath, et al.
Cancer Research
|
October 14, 2021
Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer
Rajendra Kumar, Janet Mendonca, Olutosin Owoyemi, et al.
JCO Precision Oncology
|
May 28, 2019
Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate Cancer
Samantha Torquato, Aparna Pallavajjala, Alexa Goldstein, et al.
International Journal of Environmental Health Research
|
September 7, 2023
Exploring adenovirus in water environments: a systematic review and meta-analysis
G R Takuissu, S Kenmoe, J T Ebogo-Belobo, et al.
Oncotarget
|
July 10, 2018
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer
Karim Boudadi, Daniel L Suzman, Valsamo Anagnostou, et al.
JAMA Oncology
|
March 28, 2020
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
Ryan Phillips, William Yue Shi, Matthew Deek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2025
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update
Rohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, et al.
European Urology Open Science
|
August 2, 2021
Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine
Juho Jasu, Teemu Tolonen, Emmanuel S Antonarakis, et al.
Page
of 39
Search research articles
Search
Showing results (361-370 of 386) with videos related to
Sort By:
Page
of 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2004
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group
Howard I Scher, Mario Eisenberger, Anthony V D'Amico, et al.
Cancer Research Communications
|
July 30, 2024
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial
Channing J Paller, Marianna L Zahurak, Adel Mandl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2017
Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial
Channing J Paller, Xian C Zhou, Elisabeth I Heath, et al.
Cancer Research
|
October 14, 2021
Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer
Rajendra Kumar, Janet Mendonca, Olutosin Owoyemi, et al.
JCO Precision Oncology
|
May 28, 2019
Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate Cancer
Samantha Torquato, Aparna Pallavajjala, Alexa Goldstein, et al.
International Journal of Environmental Health Research
|
September 7, 2023
Exploring adenovirus in water environments: a systematic review and meta-analysis
G R Takuissu, S Kenmoe, J T Ebogo-Belobo, et al.
Oncotarget
|
July 10, 2018
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer
Karim Boudadi, Daniel L Suzman, Valsamo Anagnostou, et al.
JAMA Oncology
|
March 28, 2020
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
Ryan Phillips, William Yue Shi, Matthew Deek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2025
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update
Rohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, et al.
European Urology Open Science
|
August 2, 2021
Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine
Juho Jasu, Teemu Tolonen, Emmanuel S Antonarakis, et al.
Page
of 39